Simplex Trading, LLC Talis Biomedical Corp Transaction History

Simplex Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$0.45 - $11.67 $45 - $1,167	100 Added 156.25%	164 $0
Q2 2022 Aug 03, 2022	SELL	$0.81 - $1.44 $810 - $1,440	-1,000 Reduced 93.98%	64 $0
Q1 2022 May 02, 2022	SELL	$1.3 - $4.19 $217 - $699	-167 Reduced 13.57%	1,064 $1,000
Q4 2021 Feb 23, 2022	BUY	$3.81 - $6.17 $4,690 - $7,595	1,231 New	1,231 $4,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.1M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.